mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |